Tugal, Roslie .
HRN: 12-32-92 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/24/2023
CEFUROXIME 1.5GM (VIAL)
04/24/2023
04/25/2023
IV
1.5
Q8
Attempted Home Delivery
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes